

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348
S313
obsessive dimensionmight have a pathoplastic influence, balancing
the effect of low disorganization symptoms.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.678EW561
Analysis of the attitudes towards the
medication in ambulatory patients
with diagnosis of schizophrenia
E. Torío
∗
, L. González Blanco , I. Abad Acebedo ,
S. Bestene Medina , J. Rodriguez Revuleta
Hospital Universitario Central de Asturias, Psiquiatría, Oviedo, Spain
∗
Corresponding author.
Introduction
The scale autoappliedDrug Attitude Inventory (DAI)
[1] isan instrument to evaluate the subjective response to the neu-
roleptics in patients diagnosed of schizophrenia. We have used the
brief version
[2] .Objectives
To study the possible relation between DAI and
sociodemographic factors [3] as well as medical treatment [4] (ref-
erences 3 and 4 are not available for this abstract).
Methods
A descriptive and comparative study. Sample of 30
patients with ambulatory follow-up from Oviedo. Sociodemo-
graphic data and drug prescription were collected.
Results
Comparative analysis: DAI and sociodemographic, drug
prescription
( Table 1 ).Correlation between DAI/age/I number of
antipsychotics
( Table 2 ).The comparative analysis only shows
positive significant correlation between DAI and antidepressant
treatment.
Conclusions
There is no correlation of DAI depending on the age
and the number of antipsychotics. The antidepressant treatment
in schizophrenic patients could be a predictor variable of better
punctuation in DAI.
Table 1
DAI mean
±
SD
Statistics
Sex: man/woman
16.21
±
2.07/16.54
±
0.93
t
= 0.50
5 aAge: <45/
≥
45
16.77
±
1.56/16.10
±
1.83
t
= –0.96
1 aPolytheraphy
16.38
±
1.83
t
= 0.40
8 aAntipsychotic:
typical/atypical
14.50
±
0.70/16.46
±
1.71
t
= –1.59
3 aDepot + oral
16.12
±
1.96
t
= –0.69
9 aAntypsichotic
depot
16.25
±
1.88
t
= –0.36
8 aBZD
16.46
±
1.59
t
= 0.41
6 aAntidepressants
yes/antidepressants
no
17.37
±
1.06/15.95
±
1.78
t
= 2.10
5 bAnticovulsants/
anticholinergics
16.37
±
1.40/15.83
±
2.13
t
= 0.07
8 a /t
= –0.78
7 aSD = Standard deviation.
a
P
≥
0.05,not significant.
b
P
< 0.05,significant.
Table 2
DAI (Correlation
Pearson)
DAI (significant)
Age
–0.05
0.79
7 aNo. of antypsichotics –0.07
0.70
0 aa
P
≥
0.05, not significant.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
References
[1] Hogan TP, Awad AG, EastwoodMR. A self-report scale predictive
of drug compliance in schizophrenia: reliability and discrimi-
nate validity. Psychol Med 1983:177–83.
[2] García-Portilla, et al. Banco de instrumentos básicos para la
práctica de la psiquiatría clínica. Barcelona: ARS MEDICA; 2008.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.679EW562
Affective psychopathology and
recognition of facial expressions in
schizophrenia and in affective
disorders
S. Trifu
1 ,∗
, L. Radoi
21
UMF Carol Davila, Psychiatry, Bucharest, Romania
2
University of Bucharest, Psychology, Bucharest, Romania
∗
Corresponding author.
Introduction
We noticed some differences between the patients
diagnosed with schizophrenia, those diagnosed with affective dis-
orders and the normal persons, as regards the empathy level, the
recognition degree of facial expressions, depression level of posi-
tive/negative affectivity.
Objectives
The exploration of its affectivity and pathology, aswell
as the changes emerging in the forming of interpersonal relation-
ships with others in schizophrenia and in affective disorders, and
the comparison of these changes with the values recorded within
the group of normal persons.
Aims
Highlighting some differences as regards aspects of affec-
tive life and forming of interpersonal relationships in patients
diagnosed with schizophrenia/affective disorder.
Methods
The instruments used: Beck’s Depression Inventory
(BDI), Toronto Empathy Questionnaire (TEQ), The Positive and Neg-
ative Affect Schedule (PANAS) and a test of identification of facial
expressions.
Results
Empathy level in close relation to type of psychiatric dis-
order (
F
= 26.84,
P
< 0.001). Depression level in relation with type of
psychic disorder (
P
< 0.001). There is a relation between the positive
affectivity and the psychiatric diagnosis of schizophrenia, affective
disorder or the absence of the diagnosis (
F
= 9.15,
P
< 0.001). The
level of negative affectivity is in relation with the psychiatric diag-
nosis (
F
=4.83,
P
= 0.011). Capacity of recognition of facial expression
in relation with psychiatric diagnosis (
P
< 0.001).
Conclusions
The conclusions of the research highlight the
changes emerging at the level of affectivity in pathology, as well
as the effects these changes have over the patient’s contact with
his/her own emotions and with the emotions of those around.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.680EW563
Evolution of schizophrenia under
treatment with atypical versus
conventional antipsychotic
S. Trifu
1 ,∗
, A. Badea
21
UMF Carol Davila, Psychiatry, Bucharest, Romania
2
University of Bucharest, Psychology, Bucharest, Romania
∗
Corresponding author.
Introduction
Over the time, schizophrenia experienced vari-
ous phases of the treatment methods, at the beginning dealing
with simple tranquillizers, more disagreeable methods follow-
ing, some of them even controversial. Finally, medical progresses